DaVita Q4 FY25: where the revenue came from and where it went
The whole income statement of DaVita for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Oct 1 – Dec 31, 2025
- Reported
- Feb 11, 2026
Revenue$3.62B
+10% year over year
Gross profit$1.03B
29% margin
Operating profit$0.56B
16% margin
Net profit$0.57B
16% margin
Net profit is larger than what operations earned, because the statement adds $0.08B below it, under Other income, net.
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 3.62 | 100% | +10% |
| US dialysis & related lab | 3.06 | 84% | +6% |
| All other | 0.56 | 16% | +33% |
| Cost of revenue | −2.59 | 71% | |
| Gross profit | 1.03 | 29% margin | −1pp |
| G&A | −0.47 | 13% | +0pp |
| Operating profit | 0.56 | 16% margin | −2pp |
| Other income, net | 0.08 | ||
| Tax | −0.08 | ||
| Net profit | 0.57 | 16% margin | −2pp |
151 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest